# Bromocriptine and Insulin Sensitivity

> **NCT02428946** · NA · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 15 (actual)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DRUG:** Bromocriptine

## Key facts

- **NCT ID:** NCT02428946
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02428946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02428946, "Bromocriptine and Insulin Sensitivity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02428946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*